SCHEMBL5176409

SCHEMBL5176409

O=Cc1c2ccccc2nn1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ NPC1 O15118 4/20 0.35
▸ TDP1 Q9NUW8 3/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ ERN1 O75460 2/20 0.33
▸ RXRA P19793 1/20 0.33
▸ MAPT P10636 6/20 0.33
▸ MEN1 O00255 5/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPK1 P28482 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4360026 0.73 ALDH1A1 (0.41) TDP1ALDH1A1L3MBTL1ERN1LMNA
SCHEMBL1149953 0.73 MPO (0.36) KMT2ARAB9ANPC1TDP1ALDH1A1
SCHEMBL5752394 0.70 MPO (0.51) RAB9ANPC1ERN1LMNAMAPK1
SCHEMBL25273272 0.69 ERN1 (0.38) KMT2AALDH1A1L3MBTL1POLBERN1
SCHEMBL28456400 0.69 MPO (0.42) KMT2ATDP1ALDH1A1L3MBTL1MAPT
SCHEMBL28707953 0.69 MPO (0.54) TDP1ALDH1A1POLBERN1MAPT
SCHEMBL18096451 0.67 PTGER4 (0.47) KMT2ARAB9AALDH1A1NPSR1L3MBTL1
SCHEMBL17981705 0.65 MPO (0.52) KMT2AALDH1A1POLBMAPTMEN1
SCHEMBL1253991 0.63 MAPT (0.38) KMT2ARAB9ANPC1TDP1ALDH1A1
SCHEMBL837902 0.63 MAPT (0.35) KMT2ARAB9ANPC1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807416-A1 NICOTINAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-18 — — EP disclosed
WO-2006048249-A1 NICOTINAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-05-11 — — WO disclosed
Send feedback